EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Timing of oral anticoagulants initiation for atrial fibrillation after acute ischemic stroke: A systematic review and meta-analysis

Lina Palaiodimou iD, Maria-Ioanna Stefanou, Aristeidis H Katsanos iD, Gian Marco De Marchis, Diana Aguiar De Sousa iD, Jesse Dawson iD, Mira Katan, Theodore Karapanayiotides, Konstantinos Toutouzas, Maurizio Paciaroni iD, David J Seiffge iD, Georgios Tsivgoulis iD

European Stroke Journal · 01.12.2024 · 9 (4) · 885-895

DOI: 10.1177/23969873241251931 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift European Stroke Journal, online erschienen am 01.12.2024. Verfasst von Lina Palaiodimou und 11 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Neurology, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. Hauptthemen laut MEDLINE: Atrial Fibrillation, Ischemic Stroke, Anticoagulants. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

There is a longstanding clinical uncertainty regarding the optimal timing of initiating oral anticoagulants (OAC) for non-valvular atrial fibrillation following acute ischemic stroke. Current international recommendations are based on expert opinions, while significant diversity among clinicians is noted in everyday practice.

Methods

We conducted an updated systematic review and meta-analysis including all available randomized-controlled clinical trials (RCTs) and observational cohort studies that investigated early versus later OAC-initiation for atrial fibrillation after acute ischemic stroke. The primary outcome was defined as the composite of ischemic and hemorrhagic events and mortality at follow-up. Secondary outcomes included the components of the composite outcome (ischemic stroke recurrence, intracranial hemorrhage, major bleeding, and all-cause mortality). Pooled estimates were calculated with random-effects model.

Results

Nine studies (two RCTs and seven observational) were included comprising a total of 4946 patients with early OAC-initiation versus 4573 patients with later OAC-initiation following acute ischemic stroke. Early OAC-initiation was associated with reduced risk of the composite outcome (RR = 0.74; 95% CI:0.56–0.98; I 2 = 46%) and ischemic stroke recurrence (RR = 0.64; 95% CI:0.43–0.95; I 2 = 60%) compared to late OAC-initiation. Regarding safety outcomes, similar rates of intracranial hemorrhage (RR = 0.98; 95% CI:0.57–1.69; I 2 = 21%), major bleeding (RR = 0.78; 95% CI:0.40–1.51; I 2 = 0%), and mortality (RR = 0.94; 95% CI:0.61–1.45; I 2 = 0%) were observed. There were no subgroup differences, when RCTs and observational studies were separately evaluated.

Conclusions

Early OAC-initiation in acute ischemic stroke patients with non-valvular atrial fibrillation appears to have better efficacy and a similar safety profile compared to later OAC-initiation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationIschemic StrokeAnticoagulantsHumansAdministration, OralTime FactorsRandomized Controlled Trials as TopicObservational Studies as Topic

Stichwörter der Autor:innen

Acute ischemic strokeatrial fibrillationintracerebral hemorrhagemeta-analysisoral anticoagulantssecondary prevention

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Second Department of Neurology, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Department of Medicine (Neurology), McMaster University/Population Health Research Institute, Hamilton, Canada.
  • Department of Clinical Research, University of Basel, Basel, Switzerland.
  • Department of Neurology and Stroke Center, Kantonsspital St. Gallen, Switzerland.
  • Department of Neurosciences (Neurology), Hospital de Santa Maria, University of Lisbon, Lisbon, Portugal.
  • Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

ORCID-Profile: Lina Palaiodimou, Aristeidis H Katsanos, Diana Aguiar De Sousa, Jesse Dawson, Maurizio Paciaroni, David J Seiffge, Georgios Tsivgoulis

Zitieren

APA

Palaiodimou, L., Stefanou, M. I., Katsanos, A. H., De Marchis, G. M., Aguiar De Sousa, D., Dawson, J., Katan, M., Karapanayiotides, T., Toutouzas, K., Paciaroni, M., Seiffge, D. J., & Tsivgoulis, G. (2024). Timing of oral anticoagulants initiation for atrial fibrillation after acute ischemic stroke: A systematic review and meta-analysis. European Stroke Journal, 9(4), 885-895. https://doi.org/10.1177/23969873241251931

Vancouver

Palaiodimou L, Stefanou MI, Katsanos AH, De Marchis GM, Aguiar De Sousa D, Dawson J, et al. Timing of oral anticoagulants initiation for atrial fibrillation after acute ischemic stroke: A systematic review and meta-analysis. European Stroke Journal. 2024;9(4):885-895. doi:10.1177/23969873241251931

BibTeX
@article{Palaiodimou2024,
  author = {Palaiodimou, Lina and Stefanou, Maria-Ioanna and Katsanos, Aristeidis H and De Marchis, Gian Marco and Aguiar De Sousa, Diana and Dawson, Jesse and Katan, Mira and Karapanayiotides, Theodore and Toutouzas, Konstantinos and Paciaroni, Maurizio and Seiffge, David J and Tsivgoulis, Georgios},
  title = {Timing of oral anticoagulants initiation for atrial fibrillation after acute ischemic stroke: A systematic review and meta-analysis},
  journal = {European Stroke Journal},
  year = {2024},
  volume = {9},
  number = {4},
  pages = {885--895},
  doi = {10.1177/23969873241251931}
}
Kostenlos starten →